On November 20, 2020, a Bloomberg article describes how Good Rx got caught in the crosshairs of an Amazon Pharma move, resulting in a $5 billion dive.
Good Rx CEO, Douglas Hirsch, is not concerned due to high barriers to entry for new players in the space. He also stated that Amazon is a partner, not a competitor.
EMJ Founder, Eric Jackson, is noted in the Bloomberg article for taking advantage of a good buying opportunity for his hedge fund.
